Observational Survey Assessing the Factors of Treatment Intensification in Uncontrolled Hypertensive Patients Under a Combination Therapy, Either Fixed or Not, of a Renin-Angiotensin System Blocker (RASB) and Hydrochlorothiazide (HCTZ), According to Their Level of Cardiovascular Risk.
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2014
At a glance
- Drugs Telmisartan (Primary) ; Hydrochlorothiazide; Telmisartan/hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms BI-INTENS
- Sponsors Bayer
- 11 Oct 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 11 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2010 Planned end date changed from 1 Jul 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.